These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6469757)

  • 1. Detection of a reactive metabolite of misonidazole in human urine.
    Varghese AJ; Whitmore GF
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1361-3. PubMed ID: 6469757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does initial haemoglobin level modify the efficacy of radiosensitizers? An analysis of the MRC misonidazole studies in head and neck cancer and cervix cancer.
    Freedman LS; Honess DJ; Bleehen NM; Adams GE; Dische S; Henk JM
    Int J Radiat Biol Relat Stud Phys Chem Med; 1987 Dec; 52(6):965-7. PubMed ID: 3500934
    [No Abstract]   [Full Text] [Related]  

  • 3. Detection of a reactive metabolite of misonidazole in hypoxic mammalian cells.
    Varghese AJ; Whitmore GF
    Radiat Res; 1984 Feb; 97(2):262-71. PubMed ID: 6538047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of the amine derivative of misonidazole in human urine by high-pressure liquid chromatography.
    Varghese AJ
    Anal Biochem; 1981 Jan; 110(1):197-200. PubMed ID: 7212263
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical experience with intravenous misonidazole for carcinoma of the esophagus: results in attempting radiosensitization of each fraction of exposure.
    Schwade JG; Kinsella TJ; Kelly B; Rowland J; Johnston M; Glatstein E
    Cancer Invest; 1984; 2(2):91-5. PubMed ID: 6733563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of bladder carcinoma with irradiation combined with misonidazole.
    Papavasiliou C; Yiogarakis D; Davillas N; Seretakis L; Pappas J; Licourinas M; Theodorou C; Stathopoulos P; Katsoyianni C; Thanos A
    Int J Radiat Oncol Biol Phys; 1983 Nov; 9(11):1631-3. PubMed ID: 6358156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined treatment of radiation and local injections of misonidazole.
    Hong SS; Abe Y; Kaneta K; Matsuzawa T
    Int J Radiat Oncol Biol Phys; 1984 Dec; 10(12):2369-73. PubMed ID: 6511531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of guanine derivatives by reduced 2-nitroimidazoles.
    Varghese AJ; Whitmore GF
    Cancer Res; 1983 Jan; 43(1):78-82. PubMed ID: 6847786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxic cell sensitizers and heavy charged particle beams may play complementary roles in killing hypoxic tumor cells.
    Curtis SB; Tenforde TS; Afzal SM
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1203-5. PubMed ID: 6432747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of hypoxic radiosensitizer after mild hyperthermia in C3H mammary carcinoma.
    Ohizumi Y; Murayama C; Maezawa H; Mori T
    Tokai J Exp Clin Med; 1984 Oct; 9(4):331-7. PubMed ID: 6537042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitroheterocyclic compounds as radiation sensitizers and bioreductive drugs.
    Adams GE; Stratford IJ; Bremner JC; Edwards HS; Fielden EM
    Radiother Oncol; 1991; 20 Suppl 1():85-91. PubMed ID: 2020774
    [No Abstract]   [Full Text] [Related]  

  • 12. [Electron acceptor compounds as radiation sensitizers of hypoxic cells in human tumors].
    Kiseleva ES; Dar'ialova SL
    Med Radiol (Mosk); 1984 Sep; 29(9):74-82. PubMed ID: 6384719
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of prolonged high dose misonidazole on tumor response to radiation.
    McNally NJ; de Ronde J; Hinchliffe M
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1281-5. PubMed ID: 6469751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irradiation with or without misonidazole for patients with stages IIIB and IVA carcinoma of the cervix: final results of RTOG 80-05. Radiation Therapy Oncology Group.
    Grigsby PW; Winter K; Wasserman TH; Marcial V; Rotman M; Cooper J; Keys H; Asbell SO; Phillips TL
    Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):513-7. PubMed ID: 10348279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical study on radiotherapy in combination with misonidazole].
    Ono K; Takahashi M; Dodo Y; Abe M
    Nihon Gan Chiryo Gakkai Shi; 1983 Aug; 18(5):1189-99. PubMed ID: 6663172
    [No Abstract]   [Full Text] [Related]  

  • 16. Current concepts in cancer: updated cervix cancer. Stages III and IV. Hyperbaric oxygen as a radiation sensitizer for carcinoma of the cervix.
    Johnson R
    Int J Radiat Oncol Biol Phys; 1979; 5(11-12):2151-5. PubMed ID: 544597
    [No Abstract]   [Full Text] [Related]  

  • 17. Cellular and chemical reduction products of misonidazole.
    Varghese AJ; Whitmore GF
    Chem Biol Interact; 1981 Aug; 36(2):141-51. PubMed ID: 7273240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase III randomized study of misonidazole plus radiation vs. radiation alone for cervix cancer.
    Chan P; Milosevic M; Fyles A; Carson J; Pintilie M; Rauth M; Thomas G
    Radiother Oncol; 2004 Mar; 70(3):295-9. PubMed ID: 15064016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The treatment of locally advanced head and neck cancer with misonidazole, hyperbaric oxygen and irradiation: an interim report.
    Sealy R; Cridland S
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1721-3. PubMed ID: 6384161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combinations of radiation and misonidazole in a murine lung tumor model.
    Siemann DW; Kochanski K
    Radiat Res; 1981 May; 86(2):387-97. PubMed ID: 7232698
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.